Chargement en cours...
Addressing the ethical, policy, and social challenges of preclinical Alzheimer disease
Research suggests that Alzheimer disease (AD) pathophysiology begins prior to the clinical expression of the disease and that biomarker measures may provide direct evidence of this process. As a result, it may be possible to uncouple the diagnosis of AD from the clinical expression of the disease. T...
Enregistré dans:
| Publié dans: | Neurology |
|---|---|
| Auteur principal: | |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Lippincott Williams & Wilkins
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4561233/ https://ncbi.nlm.nih.gov/pubmed/21917767 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0b013e318232ac1a |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|